DISHMAN CARBOGEN AMCIS
Back to Income Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹264 Cr | ₹332 Cr | ₹326 Cr | ₹274 Cr | ₹498 Cr |
What is the latest Operating Profit of DISHMAN CARBOGEN AMCIS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹264 Cr |
| Mar2024 | ₹332 Cr |
| Mar2023 | ₹326 Cr |
| Mar2022 | ₹274 Cr |
| Mar2021 | ₹498 Cr |
How is Operating Profit of DISHMAN CARBOGEN AMCIS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹264 Cr | -20.55 | |
| Mar2024 | ₹332 Cr | 2.01 | |
| Mar2023 | ₹326 Cr | 18.76 | |
| Mar2022 | ₹274 Cr | -44.89 | |
| Mar2021 | ₹498 Cr | - | |
Compare Operating Profit of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,700.1 Cr | -4.1% | -19.7% | -19% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -4.1% |
-19.7% |
-19% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses